116 related articles for article (PubMed ID: 38751877)
1. Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study.
Davoudi M; Boostani R; Manzari ZS
Iran J Med Sci; 2024 May; 49(5):294-301. PubMed ID: 38751877
[TBL] [Abstract][Full Text] [Related]
2. A significant association between CXCL10 -1447 A > G and IL18 -607 C > A gene polymorphism with human T-cell lymphotropic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM-TSP), a case-control report from city of Mashhad, Iran.
Rafatpanah H; Poursina Z; Boostani R; Marzouni HZ; Atabaki M; Hosseini RF; Tavakkol-Afshari J; Mohammadi M
J Neurovirol; 2021 Apr; 27(2):249-259. PubMed ID: 33651323
[TBL] [Abstract][Full Text] [Related]
3. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
4. An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers.
Yamauchi J; Araya N; Yagishita N; Sato T; Yamano Y
Pharmacol Ther; 2021 Feb; 218():107669. PubMed ID: 32835825
[TBL] [Abstract][Full Text] [Related]
5. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
6. Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis.
Mozhgani SH; Jahantigh HR; Rafatpanah H; Valizadeh N; Mohammadi A; Basharkhah S; Rezaee SA
Neurodegener Dis; 2018; 18(2-3):150-155. PubMed ID: 29990995
[TBL] [Abstract][Full Text] [Related]
7. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
8. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
9. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
11. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
12. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
13. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
[TBL] [Abstract][Full Text] [Related]
15. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
16. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Saito M; Tanaka R; Arishima S; Matsuzaki T; Ishihara S; Tokashiki T; Ohya Y; Takashima H; Umehara F; Izumo S; Tanaka Y
Retrovirology; 2013 May; 10():51. PubMed ID: 23651542
[TBL] [Abstract][Full Text] [Related]
18. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Nakamura T; Nishiura Y; Eguchi K
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
[TBL] [Abstract][Full Text] [Related]
20. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Okajima R; Casseb J; Sanches JA
Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
